Baktar (Trimethoprim-sulfamethoxazole) 的life-threatening effect較容易發生在HIV、嗜中性球低下或對成分過敏患者。其中trimethoprim會抑制遠曲小管的Na+ channel,造成intracellular sodium濃度下降,進而降低Na+/K+ATPase function,導致滯留於血漿中的K+濃度上升。
Trimethoprim導致高血鉀的機轉與amiloride雷同,兩者在結構上也相似。
Trimethoprim ➝抑制➝ Na+ channel ➝➝ intracellular sodium concentration decrease ➝➝ serum potassium level increase
由於可能造成血鉀濃度上升,renal impairment或年紀大患者使用Baktar時若有並用會造成高血鉀的藥品,如spironolactone或ACEI、ARB、NSAIDs要留意血鉀濃度變化。
Risk factor
- High dosage (20 mg/kg/day of trimethoprim)
- Renal impairment (serum creatinine ≥ 1.2 mg/dl)
- Hypoaldosteronism
- Potassium-altering medications
- NSAIDs
- ACEI, ARB
- Potassium-sparing diuretics
- Older age
Prevention and management of baktar-induced hyperkalaemia
- Induction of high urine flow rates and enhanced sodium delivery to the distal nephron
- IV saline
- Loop diuretics (if volume-replete)
- 鹼化尿液 (goal: pH ≥ 7.5)
- sodium bicarbonate
- acetazolamide
- 劑量調整 (if renal impairment)
- Ccr < 30 ml/min, 減半
- Ccr < 15 ml/min, avoid
- 嚴重高血鉀&renal failure → 停用
References
- Uptodate.com. 2021. UpToDate. [online] Available at: <https://www.uptodate.com/contents/trimethoprim-sulfamethoxazole-an-overview?search=sulfamethoxazole%20trimethoprim&usage_type=default&source=search_result&selectedTitle=1~150&display_rank=1> [Accessed 20 July 2021].
- Perazella, M., 2000. Trimethoprim-Induced Hyperkalaemia. Drug Safety, 22(3), pp.227-236.
自動引用通知: 急性甲溝炎治療 | Acute Paronychia – 少年維特藥學部落格
自動引用通知: DKA 與 HHS 比較 – 少年維特藥學部落格
自動引用通知: 台大輸液No.1~5比較表 – 少年維特藥學部落格